公开(公告)号：US20240148818A1

公开(公告)日：2024-05-09

申请号：US18518134

申请日：2023-11-22

申请人： Seinda Pharmaceutical Guangzhou Corporation

发明人： Zuguo Liu ,  Yufen Zhao ,  Caihong Huang ,  Yang Wu ,  Guo Tang ,  Yan Liu ,  Pengxiang Xu

IPC分类号： A61K38/05 ,  A61K9/00 ,  A61K47/02 ,  A61K47/14 ,  A61K47/18 ,  A61K47/36 ,  A61P27/04

CPC分类号： A61K38/05 ,  A61K9/0048 ,  A61K47/02 ,  A61K47/14 ,  A61K47/186 ,  A61K47/36 ,  A61P27/04

摘要： The invention relates to an ophthalmic pharmaceutical composition and its preparation methods and applications, wherein the pharmaceutical composition comprises of L-Alanyl-L-Glutamine suspended or dissolved in an isoosmotic solution suitable for human eyes, and has the advantages causing minimal irritation, with high stability and a good safety profile, and which can be used for relieving dry eye disease (DED) symptoms and/or improving and/or treating DED.

公开(公告)号：US20210030833A1

公开(公告)日：2021-02-04

申请号：US16964108

申请日：2019-01-22

申请人： Seinda Pharmaceutical Guangzhou Corporation

发明人： Zuguo Liu ,  Yufen Zhao ,  Caihong Huang ,  Yang Wu ,  Guo Tang ,  Yan Liu ,  Pengxiang XU

IPC分类号： A61K38/05 ,  A61K9/00 ,  A61K47/36 ,  A61K47/02 ,  A61K47/14 ,  A61K47/18 ,  A61P27/04

摘要： The invention relates to an ophthalmic pharmaceutical composition and its preparation methods and applications, wherein the pharmaceutical composition comprises of L-Alanyl-L-Glutamine suspended or dissolved in an isoosmotic solution suitable for human eyes, and has the advantages causing minimal irritation, with high stability and a good safety profile, and which can be used for relieving dry eye disease (DED) symptoms and/or improving and/or treating DED.